WO2007110765A3 - Processes for the preparation of octreotide - Google Patents
Processes for the preparation of octreotide Download PDFInfo
- Publication number
- WO2007110765A3 WO2007110765A3 PCT/IB2007/000800 IB2007000800W WO2007110765A3 WO 2007110765 A3 WO2007110765 A3 WO 2007110765A3 IB 2007000800 W IB2007000800 W IB 2007000800W WO 2007110765 A3 WO2007110765 A3 WO 2007110765A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- octreotide
- processes
- preparation
- pharmaceutically acceptable
- acceptable salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to processes for the preparation of pure octreotide or pharmaceutically acceptable salts thereof. The invention also relates to an amorphous form of octreotide and processes for the preparation of amorphous form of octreotide or pharmaceutically acceptable salts thereof. The invention also relates to pharmaceutical compositions that include the pure octreotide or the amorphous octreotide or pharmaceutically acceptable salts thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07734124A EP2013226A2 (en) | 2006-03-28 | 2007-03-28 | Processes for the preparation of octreotide |
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN457/MUM/2006 | 2006-03-28 | ||
| IN454MU2006 | 2006-03-28 | ||
| IN455MU2006 | 2006-03-28 | ||
| IN456/MUM/2006 | 2006-03-28 | ||
| IN455/MUM/2006 | 2006-03-28 | ||
| IN457MU2006 | 2006-03-28 | ||
| IN454/MUM/2006 | 2006-03-28 | ||
| IN456MU2006 | 2006-03-28 | ||
| IN1372/MUM/2006 | 2006-08-31 | ||
| IN1382/MUM/2006 | 2006-08-31 | ||
| IN1382MU2006 | 2006-08-31 | ||
| IN1372MU2006 | 2006-08-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007110765A2 WO2007110765A2 (en) | 2007-10-04 |
| WO2007110765A3 true WO2007110765A3 (en) | 2009-04-16 |
Family
ID=38541506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2007/000800 Ceased WO2007110765A2 (en) | 2006-03-28 | 2007-03-28 | Processes for the preparation of octreotide |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2013226A2 (en) |
| WO (1) | WO2007110765A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2435780C1 (en) * | 2010-07-08 | 2011-12-10 | Закрытое Акционерное Общество "Фарм-Синтез" | Method for producing cyclic peptide-octreotide |
| RU2441018C1 (en) * | 2010-09-28 | 2012-01-27 | Закрытое Акционерное Общество "Фарм-Синтез" | Method of chromatographic purification of octreotide |
| US20140296144A1 (en) | 2011-09-30 | 2014-10-02 | Mylan Laboratories, Ltd. | Process for the preparation of octreotide acetate |
| WO2013132505A1 (en) | 2012-03-09 | 2013-09-12 | Natco Pharma Limited | Improved process for preparation of octreotide by solution phase peptide synthesis |
| CN104513293A (en) * | 2013-09-26 | 2015-04-15 | 深圳信立泰药业股份有限公司 | Polypeptide vaccine salt, preparation method thereof, and medicinal product containing salt |
| WO2017175107A1 (en) * | 2016-04-04 | 2017-10-12 | Emcure Pharmaceuticals Limited | Process for preparation of octreotide acetate |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4395403A (en) * | 1979-11-27 | 1983-07-26 | Sandoz Ltd. | Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use |
| US6987167B2 (en) * | 2002-05-22 | 2006-01-17 | Wockhardt Limited | Process for production of the somatostatin analog, octreotide |
-
2007
- 2007-03-28 EP EP07734124A patent/EP2013226A2/en not_active Withdrawn
- 2007-03-28 WO PCT/IB2007/000800 patent/WO2007110765A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4395403A (en) * | 1979-11-27 | 1983-07-26 | Sandoz Ltd. | Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use |
| US6987167B2 (en) * | 2002-05-22 | 2006-01-17 | Wockhardt Limited | Process for production of the somatostatin analog, octreotide |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2013226A2 (en) | 2009-01-14 |
| WO2007110765A2 (en) | 2007-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009114118A3 (en) | Oral pharmaceutical compositions of buprenorphine and method of use | |
| WO2008066899A3 (en) | Nanoparticulate formulations and methods for the making and use thereof | |
| WO2007087431A3 (en) | Sublingual fentanyl spray | |
| WO2009017837A3 (en) | Sublingual fentanyl spray | |
| WO2007027527A3 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
| WO2012021715A3 (en) | Stable formulations of linaclotide | |
| WO2009084024A3 (en) | A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof | |
| WO2007135527A3 (en) | Benzimidazolyl compounds | |
| WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
| IL181827A0 (en) | Donepezil salts suitable for the preparation of pharmaceutical compositions | |
| WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| WO2008083130A3 (en) | Amorphous and crystalline form a of carvedilol phosphate | |
| WO2011023367A3 (en) | Bisphosphonate-prodrugs | |
| AP2714A (en) | Orodispersible pharmaceutical composition for or omucosal or sublingual administration of agomelati ne | |
| WO2008088779A3 (en) | Solid state forms of 5-azacytidine and processes for preparation thereof | |
| WO2008035380A3 (en) | An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts | |
| WO2008051564A3 (en) | Crystalline forms of palonosetron hydrochloride | |
| WO2007110765A3 (en) | Processes for the preparation of octreotide | |
| WO2008104852A3 (en) | Pharmaceutical compositions comprising adsorbate of fenofibrate | |
| WO2008081268A3 (en) | Pharmaceutical compositions of entacapone | |
| WO2008137134A3 (en) | Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide | |
| WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
| WO2007125521A3 (en) | Polymorphic form of zoledronic acid and processes for their preparation | |
| WO2010061220A3 (en) | Novel processes and pure polymorphs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07734124 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2007734124 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2113/MUMNP/2008 Country of ref document: IN |